Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2
Yosuke Maeda(Kumamoto University), Shuzo Matsushita(Kumamoto University Hospital)
Cited by 6
Related Papers
Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26
|Clinical Infectious Diseases|2007|222